Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical cord mesenchymal stem cell transplantation for chronic brainstem disease
ChiCTR-TNC-11001486Phase 2Completed
- Sponsor
- The Third Medical Center of the Chinese People's Liberation Army General Hospital
- Start
- Sep 2011
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of human umbilical cord mesenchymal stem cells in brainstem disease, Brainstem hemorrhage (PBSH), brainstem stroke (BSS) and 2 more, sponsored by The Third Medical Center of the Chinese People's Liberation Army General Hospital. Primary endpoint: Electrophysiology assessment. Started Sep 2011; status: completed.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
brainstem diseaseBrainstem hemorrhage (PBSH)brainstem stroke (BSS)Brainstem injuryBrainstem encephalomalacia
Beyond the preview
Go deeper on ChiCTR-TNC-11001486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNC-11001486.